Title : Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing rats.

Pub. Date : 2005 Jul

PMID : 15930896






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing rats. liposomal doxorubicin tumor necrosis factor-like Rattus norvegicus
2 Addition of low-dose TNF augmented the anti-tumor activity of Doxil, although no increased drug uptake was found compared to Doxil alone. liposomal doxorubicin tumor necrosis factor-like Rattus norvegicus